Bignan; Gilles C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bignan; Gilles C..The latest application filed is for "imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer".

Company Profile

0.10.9

Bignan; Gilles C. - Bridgewater NJ
Bignan; Gilles C. - Brigewater NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazolin-5-one Derivative Useful As Fasn Inhibitors For The Treatment Of Cancer App 20180327401 - Connolly; Peter J. ; et al.	2018-11-15
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer Grant 10,077,261 - Connolly , et al. September 18, 2	2018-09-18
Imidazolin-5-one Derivative Useful As Fasn Inhibitors For The Treatment Of Cancer App 20160002219 - Connolly; Peter J. ; et al.	2016-01-07
1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor Grant 8,741,916 - Bignan , et al. June 3, 2	2014-06-03
Substituted phenoxy aminothiazolones as estrogen related receptor-.alpha. modulators Grant 8,580,832 - Gaul , et al. November 12, 2	2013-11-12
Substituted pyrimidinyl oxime kinase inhibitors Grant 8,367,825 - Guozhang , et al. February 5, 2	2013-02-05
Substituted Pyrimidinyl Oxime Kinase Inhibitors App 20120157412 - Battista; Kathleen A. ; et al.	2012-06-21
Substituted pyrimidinyl oxime kinase inhibitors Grant 8,153,791 - Xu , et al. April 10, 2	2012-04-10
3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators Grant 7,655,670 - Battista , et al. February 2, 2	2010-02-02
Thia-tetraazaacenaphthylene kinase inhibitors Grant 7,579,356 - Battista , et al. August 25, 2	2009-08-25
1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one Derivatives As Ligands Of The Orl-1 Receptor App 20080249122 - BIGNAN; Gilles C. ; et al.	2008-10-09
SUBSTITUTED PHENOXY AMINOTHIAZOLONES as estrogen related receptor-alpha modulators App 20080221179 - Gaul; Michael ; et al.	2008-09-11
Substituted Thienopyrimidine Kinase Inhibitors App 20080108611 - Battista; Kathleen A. ; et al.	2008-05-08
3-piperidin-4-yl-indole Orl-1 Receptor Modulators App 20080015214 - Bignan; Gilles C. ; et al.	2008-01-17
Thia-tetraazaacenaphthylene kinase inhibitors App 20070265264 - Battista; Kathleen A. ; et al.	2007-11-15
Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators App 20070112016 - Battista; Kathleen A. ; et al.	2007-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.